Prof. dr Aleksandra Pavlović

neurologist

Prof. dr Aleksandra Pavlović

Education:

  • 1988-1993 basic studies, Faculty of Medicine, University of Belgrade
  • 1994-1999 specialization in neurology
  • 1999 master’s thesis, Faculty of Medicine, University of Belgrade, “Correlation of endocranial computed tomography findings and clinical picture in patients with closed craniocerebral injury”
  • 2007 doctoral dissertation, Faculty of Medicine, University of Belgrade, “Aetiopathogenesis and clinical manifestations of adult leukoencephalopathy”

Work experience:

  • 1994 – 1999 specialist in neurology, Neurology Clinic of the Clinical Center of Serbia
  • 2000 – 2020 neurology specialist, Neurology Clinic of the Clinical Center of Serbia
  • 2011-2019 clinical assistant, Department of Neurology, Faculty of Medicine, University of Belgrade
  • 2019 – 2020 assistant professor, Department of Neurology, Faculty of Medicine, University in Belgrade
  • 2020 – 2024 assistant professor, Faculty of Special Education and Rehabilitation, University of Belgrade
  • From 2024, associate professor, Faculty of Special Education and Rehabilitation, University of Belgrade
  • Since 2020, he has been teaching at the Department of Psychology, Faculty of Philosophy, University of Belgrade

Professional training:

  • 2000 – 2021 Stroke Unit, Ichilov Hospital, Sourasky Medical School, Tel Aviv, Israel; mentor Prof. Nathan Bornstein
  • 2002 Department of Neurology, Wilhelminenspital, Vienna, Austria; mentor Prof. Thomas Brücke
  • 2003 Baylor College of Medicine, Department of Neurology and Alzheimer’s Disease Research Center, Houston, Texas, USA; mentor Prof. Rachel Doody Smith
  • 2004 Stroke Treatment Center, Hermann Hospital, The University of Texas, Houston; mentor Prof. Andrei V. Alexandrov; Comprehensive Examination in Neurosonology: Carotid and Transcranial Doppler, American Society of Neuroimaging
  • 2005 – 2006 Stroke Research Fellow, Department of Neurology, Royal Melbourne Hospital, University of Melbourne, postgraduate studies, mentor Prof. Stephen M. Davis
  • 2018 University College Hospitals London – Neurology at the Queen Square, Stroke Research Centre, mentor Prof. David Werring

Area of interest:

Cerebrovascular diseases, diseases of small blood vessels of the brain, cognitive and behavioral disorders, headaches, dizziness, neurosonology

Professional memberships:

• MENSA Serbia; Neurological Section of the Serbian Medical Society; Society of Neurologists of Serbia; European Stroke Organization (ESO) – member of Dementia Committee, Membership Committee, Educational Committee, WISE (Women Initiative for Stroke in Europe) working group; European Society of Neurosonology and Cerebral Hemodynamics (ESNCH)/World Organization of Neurosonology (WON) – Ambassador for Serbia; World Stroke Organization (WSO) – GENder Equity and Diversity In Stroke Care Committee (GENESIS)

Publications:

• Author of 501 works in the field of neurology, neurosonology, neuropsychology, of which 84 works in journals from the JCR list, with a total impact factor of 227.
• Citations: 1876, h-index 22, i10-index 41
• Author/co-author of 8 books in the field of neurology

Languages:

English

Dr Jelena Jovanović

general practitioner

Dr Jelena Jovanović

Education:

  • 2017 – 2024. Faculty of Medicine, University of Belgrade
  • from 2025. resident doctor in the field of radiology at the Medical Faculty of the University of Belgrade

 

Work experience:

from 2025. general practitioner, resident doctor in the field of radiology, Ars Medica Beograd

 

Dr Natalija Ajdačić

general practitioner

Dr Natalija Ajdačić
Education:
  • 2024. Faculty of Medicine, University of Belgrade
  • 2025. resident doctor in the field of radiology at the Medical Faculty of the University of Belgrade
Work experience:
  • 2025. volunteer, GAK “ Narodni front”
  • 2025. general practitioner, resident doctor in the field of radiology, Ars Medica Beograd

Spec. dr med. Feđa Đorđević

oncologist

Spec. dr med. Feđa Đorđević

Education:

  • MD: 2010, School of Medicine, University of Belgrade,
  • Internship: 2010, Clinical Centre of Serbia
  • Residency: 2020 Medical oncology, Clinical Centre of Serbia and Institute for oncology and radiology of Serbia
  • PhD studies: 2016, Tumor biology (started), School of Medicine, University of Belgrade

Proffesional training:

July 2008: International exchange of medical students of the International Federation of Medical Student Associationes, Department of Cardiology, Kaunas , Lithuania
March 2013: ESO course: Visiting Professorship on Lung Cancer, Belgrade,Serbia
May 2013: 3rd ESO Masterclass in Clinical Oncology, Dubrovnik, Croatia
March 2014: European Union project “Development of palliative care in Serbia”- Principles and philosophy of palliative care, palliative care knowledge and skills development, part 1, 2 and 3, Belgrade,Serbia
March 2015: 1stAROME Masterclass in molecular oncology, Skopje, Macedonia
March 2015: Eastern Europe and Balkan Region Refresher Course on Lung Cancer, Belgrade, Serbia
July 2015: 2nd ESO-ESMO Masterclass in Clinical Oncology, Bratislava, Slovakia
Dec 2016: The First Regional Educational Meeting on Supportive Care in Cancer Patients for Eastern Europe and the Balkan region, Belgrade, Serbia
May 2017: The First Regional Congress of Medical Oncology, Dubrovnik, Croatia
May 2017: Central European Cooperative Oncology Group (CECOG) Preceptorship program on Immuno Check point inhibition, Vienna, Austria
May 2017: Scientific Days of the Oncology Institute, Bucharest, Romania
May 2017: ESMO Preceptorship on Immune-Oncology Amsterdam, Holland
July 2017: 4th ESO-ESMO Masterclass in Clinical Oncology, Belgrade, Serbia
Dec 2017: The Second Regional Educational Meeting on Supportive Care in Cancer Patients for Eastern Europe and the Balkan region, Belgrade, Serbia
Dec 2017: Open Medical Institute Seminar: Palliative Care in Pediatrics, Salzburg, Austra
Feb 2018: Central European Cooperative Oncology Group (CECOG) „Multidisciplinary Course of Thoracic Malignancies“ in Brdo, Slovenia
March 2018: ESMO-The Christie Preceptorship on Lung Cancer Manchester United Kingdom
May 2018: 13 th Belgrade International Symposium on Pain , Belgrade Serbia
Jun 2018: MASCC/ISOO 2018 Annual Meeting on Supportive Care in Cancer, Vienna ,Austria
Sep 2018: Society of Hematologic Oncology (SOHO), Houston USA
Nov 2018 ESO ASCO Masterclass in Clinical Oncology, Yerevan, Armenia
Sep 2019: 9 th Congress of General Practise Medicine in Serbia
Apr 2019 5th ESO-ESMO Masterclass in Clinical Oncology, Sibenik, Croatia
Oct 2019 ESMO Preceptorship on Breast Cancer, Lisbon, Portugal
2020 International Development and Education Award (IDEA) by the Conquer Cancer Foundation and ASCO. This award will enable recipient to attend the ASCO 2020 meeting and an observership at the Cancer Center with a mentorship
2021 CECOG Young Oncologist Leadership Program
2022 ESMO Preceptorship for Gastric cancer, Valencia ,Spain
2023 ESMO Advanced course in NSCLC with oncogenic driver mutations Barcelona, Spain

Cinical trials:

Various randomized multicentre international phase III clinical trials and randomized bioequivalence studies

Memberships:

1. Multinational association for supportive care in cancer (MASCC)
2. European Society for Medical Oncology (ESMO)
3. Serbian Medical Society-general secretary
4. Serbian Society of Medical Oncology
5. European Association for Cancer Research (EACR)
6. Serbian Association for Cancer Research (SDIR)
7. Society of Hematologic Oncology (SOHO) – Ambassador to Serbia

Publications:

I Abstracts from International congresses /Abstract Books/:
1. Nikolić V, Josifovski J, Radosavljević D, Nikolić N, Ristić M, Djordjević F, Čavić M, Jakovljević K, Janković R, Gavrilović D:
Efficasy of the combination of Irinotecan and Cetuximab in treating patients with chemotherapy refractory metastatic colorectal cancer- preliminary results- Arch.of Gastroenterohepatology, oct 2011,Vol.28, No1-2,p.104,PP32

2. Spasić J, Krivokuća, A, Čavić, M, Jakovljević, K, Mališić E, Ristić, M, Djordjević F, Radosavljević D, Janković R.
Thymidylate synthase gene polymorphisms and lung adenocarcinoma in Serbia. 3rd European Lung Cancer Conference. J Thorac Oncol. 2012,7(6), Supplement 1:S42 (abstract id. 113P)

3. Spasić J, Stanic N, Djordjević F, Ristić M, Nikolić N, Radosavljević D.
Is there an association between the occurrence of neutropenia and neuropathy in patients with metastatic colorectal cancer treated with Folfox Ann Oncol (2013) 24 (suppl 4): iv97

4. J.Dimitrijevic , S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic. The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients admitted to Clinic for medical oncology, Instutute for oncology and radiology of Serbia. 2nd Regional Congress on Supportive Care in Oncology. Abstract book (2014)

5. Djordjevic F, Bosnjak S, Dimitrijevic J, Stanic N, Bakic N, Susnjar S. Hydromorphone SR effective and safe for the treatment of cancer dyspnea in lung cancer patients: positive preliminary results. Support Care Cancer 2015, 23 (Suppl 1): S260

6. Spasic J, Stanic,N, Ristic M, Djordjevic F , Nikolic N, Nikolic V, Pupovac S, Radosavljevic,D. (2015). Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia. Annals of Oncology. 26. 10.1093/annonc/mdv233.276.

7. Bosnjak S, Dimitrijevic J, Djordjevic F. Cancer and Chemotherapy-induced Nausea and Vomiting: A focus on olanzapine. Current Opinion in Supportive & Palliative Care (2016), 10:180–188

8. Scientific Days of the Oncology Institute, May 2017,Bucharest, Romania- abstract book: F.Djordjevic. Serbian model of integration of Palliative care into Oncology practice

9. Spasic J, Stanic N, Djordjevic F , Ristic M, Nikolić V, Radosavljevic, Davorin. (2017). Mitomycin-c (mtc) as salvage therapy for patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 28. 10.1093/annonc/mdx261.321

10. Spasic, J,Stanic, N, Djordjevic F, Jokic V Radosavljevic D (2018). P3.01-92 Blood Test Parameters as Prognostic Factors In EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs. Journal of Thoracic Oncology. 13. S902. 10.1016/j.jtho.2018.08.1652.

11. Radosavljevic D, Spasic J, Ristic M , Nikolic V , Nikolic N, Stanic, N. , Djordjevic F, Gavrilović, Dušica. (2018). P3.01-85 Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations – Serbian Single Center Experience. Journal of Thoracic Oncology. 13. S899. 10.1016/j.jtho.2018.08.1645.

12. Djordjevic F. Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) (2018) Clinical Lymphoma, Myeloma and Leukemia, Volume 18, S238

II Abstracts from National congresses /Abstract Books/:
1. Section of oncology of Serbian Medical Society 52 th annual meeting, abstract book: F.Djordjevic. Dyspnea in advanced cancer patients: ESMO Clinical Practice Guidelines (2015)

2. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Dyspnea in patients with lung cancer (2016)

3. 7th Serbian-French Oncology Congress, March 2016 Novi Sad, Serbia- abstract book: Morphine: Cancer Pain and Dyspnoea

4. Section of oncology of Serbian Medical Society 53 th annual meeting, abstract book: J.Dimitrijevic, S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic.The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients with melanoma admitted to Clinic for medical oncology (CMO), Instutute for oncology and radiology of Serbia (IORS) (2016)

5. Section of oncology of Serbian Medical Society 54 th annual meeting, Belgrade, Serbia, November 2017- abstract book: Djordjevic F, Stanic N, Dimitrijevic J, Spasic J, Zilic A, Bosnjak S, Radosavljevic D, Susnjar S. The efficacy and tolerability of slow release hydromorphone in the treatment of cancer dyspnea in lung cancer patients: experience from the Institute for Oncology and Radiology of Serbia

6. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Immunotherapy in the first line treatment in patient with NSCLC (2018)

III Books and Monographies/Brochures:

1. Educational brochure for patients about prevention and therapy of chemotherapy induced nausea and vomiting for Serbian Society for the Fight Against Cancer (2015)

2. Educational brochure for patients about supportive oncology for Institute for oncology and radiology of Serbia (2015)

Prim. dr sci. med. Davorin Radosavljević

oncologist

Prim. dr sci. med. Davorin Radosavljević

Education:

1982. Basic studies, Faculty of Medicine, University of Belgrade
1991. Specialization in Internal Medicine, Faculty of Medicine, University of Belgrade
1996. Master’s degree in oncology, with the thesis “The importance of assessing the quality of life in the selection of a chemotherapy regimen for the treatment of patients with advanced squamous cell lung cancer“, at the Faculty of Medicine in Belgrade
2007. Title of primarius
2008. PhD with the dissertation “Prognostic model of advanced non-small cell lung cancer in patients treated with chemotherapy

Work experience:

1985 to 2024. Employed at the Clinic for Medical Oncology
2001. Head of the Department for Chemotherapy of Solid Tumors
2011 – 2024. Director of the Clinic for Medical Oncology
2017. Adjunct Professor at the Faculty of Medicine in Belgrade

Scientific titles and participation in scientific projects:

Gained research associate title in 2009, the first re-election in January 2015, the last on January 22, 2020.

Areas of interest and scientific research are systemic chemotherapy of solid malignant lung tumors, digestive tract and urological tumors.

Participated in scientific projects of the Ministry of Science 13M13, 1996-2000. (head of NSav Dr. N. Mitrović) and 145055, 2005-2010. (head of NSav Dr. S. Jelić).

From 2011-2015. participates in two projects: Pharmacodynamics and pharmacogenomics of testing new drugs in the treatment of solid tumors, 41026, head of NSav Dr. Siniša Radulović and Role of preoperative determination of disease stage, prognostic and therapeutic markers, objectification of functional results in the decision on the strategy of rectal cancer treatment, and with the aim of improving oncological results and quality of life, 41033, head of Prof. Dr. Zoran Krivokapić.

Lectures at European meetings:

Lecturer at the 11th European Congress on Public Health in Ljubljana on November 30, 2018. Title: “The role of a Cancer Control Plan in Advancing Patient Outcomes

Lecturer by invitation at the meeting Cost Action CA17404 “New diagnostic and therapeutic tools against multidrug resistant tumors” Belgrade, 27/28.02.2020. Title: “Targeted therapies in oncology – advantage and resistance

Professional work in expert commissions and associations in Serbia:

For the National Guide for the Diagnosis and Treatment of Lung Cancer 2011. wrote a chapter on chemotherapy for advanced non-small cell lung cancer. For the 2012 National Guide for the Treatment and Diagnosis of Colon and Rectal Cancer. wrote a chapter on adjuvant and systemic chemotherapy for colorectal cancer.

President of the Subcommittee for Antineoplastic Medicines of the Central Committee for Medicines of the RFZO 2004-2012.

Member of the Republic Expert Commission for Oncology since 2014. and the Republican Expert Commission for Cytotoxic and Molecularly Targeted Medicines of the Ministry of Health 2015-2019. Previously, a member of the Subcommittee for Medicines of the RSK for oncology since 2008. ALIMS external expert since 2004.

Vice President of the Central Commission for Medicines of the RFZO from 2021.

Memberships in professional associations:

Member of the SLD Cancer Section since 1986. secretary of the Section 1995-2001, member of the Presidency.
Member of the Presidency of the Association of Medical Oncologists of Serbia (UMOS) since its foundation in 2005.
Member of the European Association of Medical Oncologists (ESMO) since 1996. and the American Society of Clinical Oncologists (ASCO) since 2003.
Member of the Balkan Union of Oncologists (BUON) since 1996, member of the Editorial Board of J of BUON.
Member of the Central European Cooperative Oncology Group (CECOG) since 2004

Doc. dr Maja Milovanović

neurologist

Doc. dr Maja Milovanović

Education:

  • 1993. Basic studies, Faculty of Medicine, University of Belgrade
  • 1999. Specialization in neurology, Faculty of Medicine, University of Belgrade
  • 1999. Professional education in electroencephalography (EEG) with Prof. Dr. Žarko Martinović under the auspices of the Association for Clinical Neurophysiology SCG, for 9 months at the Institute for Mental Health, Belgrade.
  • 2002. Master’s studies in the field of neurology, Faculty of Medicine, University of Belgrade
  • 2010. Doctoral dissertation “Quality of life of patients with epilepsy”, mentor Prof. Dr. Žarko Martinović, Faculty of Medicine, University of Belgrade
  • 2021. Subspecialization in clinical neurophysiology with epileptology, Faculty of Medicine, University of Belgrade

Work experience:

  • Since 1994, she has been employed in the Department of Epilepsy and Clinical Neurophysiology of the Institute of Mental Health, and since 2010 she has been the head of the Department.
  • In 2017, she was elected, and in 2022, re-elected to the position of assistant professor for the narrow scientific field of neurology at the Faculty of Special Education and Rehabilitation, University of Belgrade.

Special interest:

Continuous training and research in the field of epileptology and electroencephalography (EEG) within the framework of educational courses, workshops and congresses organized by the International League against Epilepsy and national associations. Principal investigator in clinical studies of antiepileptic drugs and national coordinator of the international registry of pregnancy and antiepileptic drugs – EURAP studies (European Registry of Antiepileptic Drugs in Pregnancy) for Serbia and Montenegro since 2014.

Memberships:

  • Association of Neurologists of Serbia
  • European Academy of Neurology
  • Serbian League for the fight against epilepsy
  • Association for Clinical Neurophysiology of Serbia, member of the presidency
  • Serbian Medical Society

Foreign languages:

English

Dr Aleksandar Komnenov

radiologist

Dr Aleksandar Komnenov

Education:

  • 1995 basic studies at the Faculty of Medicine, University of Belgrade
  • 2001 specialization in radiology, Faculty of Medicine, University of Belgrade

Work experience:

  • 1995 – 2000 GZZHMP Belgrade
  • 2001 – 2003 radiology specialist, KBC Bežanijska kosa, Belgrade
  • 2003 – 2006 Norrkoping Regional Hospital, Sweden, Department of General Radiology with Acute and Interventional Radiology
  • 2006 – 2011 Nortelje General Hospital, Stockholm, Sweden, Department of General Radiology with Acute and Interventional Radiology
  • 2011 – 2018 Linköping University Hospital, Sweden, Department of Musculoskeletal Radiology, Rectorate of Teaching – medical responsible and main responsible for magnetic resonance imaging of the musculoskeletal department, responsible for CT, skeletal pathology punctures, part of the responsibility for resident education and teaching
  • 2016 – 2023 TMC-Telemedicineclinic with TMC Academy, Barcelona, ​​Spain, musculoskeletal radiologist in one of the leading departments of musculoskeletal radiology in Europe
  • 2023 – 2024 Teleconsult, Barcelona, ​​Spain, Specialized Department of Musculoskeletal Radiology, General Radiology
  • 2023 – 2024 Lofoten-Gravdal General Hospital, Norway – Specialist in musculoskeletal radiology and sports medicine, general, acute and interventional radiology
  • 2024 Ars Medica Belgrade, radiology specialist

Professional training:

  • 2003 Linköping University Hospital – Three-month course: contrast ultrasound
  • 2004 Sahlgrenska University Hospital, Gothenburg – HRCT pattern of changes in chronic,
    fibrotic lung diseases
  • 2005 Karolinska University Hospital, Stockholm – Two-month education at pediatric department
  • 2006-2007 Sankt Goran specialized orthopedic hospital, Stockholm – MSK education
  • 2008 RSNA Chicago – Annual Conference Society of Radiologists of North America
  • 2009 MSK congress, Davos
  • 2010 Bologna University Hospital, Sarcoma Center – Three-month education
  • 2011 Radiology Congress, Davos – Neuro radiology with an emphasis on pathologies on spine
  • 2012 RSNA Chicago – Annual Conference Society of Radiologists of North America
  • 2012 MSK Association of Swedish Radiologists – Member the Committee
  • 2013 Stoller workshop and Congres MSK, Las Vegas
  • 2014 Resnik workshop and Congress, Copenhagen – Academy: rheumatic diseases and upper extremities
  • 2015 – 2020 TMC Barcelona – Annual MSK congresses with the most prominent lecturers from MSK area (Resnik, Pomeranz)
  • 2016 and 2021 RSNA London and Barcelona – Annual congresses
  • 2022 Balgrist University Hospital Zurich – MSK workshop and congress: Pathology of the hand wrist, hand and foot with reference to ultrasound

Dr med. Dragana Bjelica

radiologist

Dr med. Dragana Bjelica

Education:

  • 2007 Undergraduate studies, Faculty of Medicine, University of Belgrade

Work experience:

  • 2008 Clinical physician, KBC Bežanijska kosa, Belgrade
  • 2013-2017 Doctor on specialization, KBC Bežanijska kosa, Belgrade
  • since 2017 Doctor specialist in radiology, KBC Bežanijska kosa, Belgrade

Memberships:

  • since 2007 Serbian Medical Association
  • since 2007, Medical Chamber of Serbia
  • since 2022 Serbian Senology Society

Professional training:

  • 2017 Breast MRI School, KBC Bežanijska kosa, Belgrade
  • 2017 Japanese project for improvement of the national program for early detection for BC, IZJZS Batut, Belgrade
  • 2018 Detection and diagnosis of breast diseases using multimodality approach course (L. Tabar), Mammography Education Inc.
  • 2018 Doppler sonography and CT angiography, Imaging Club, Association for Medical Imaging of Serbia
  • 2019 Belgrade MRI breast workshop, IORS

Professional texts and references:

2011 Modern approach in the diagnosis of rare anomaly of coronary arteries (common origin of coronary arteries). Case presentation. Bjelica D, Šaponjski J, Aleksić A, Pendić-Polak S.

2022 Sentinel lymph node identification with dye and intraoperative axillary palpation in breast cancer: Single institution experience. Loboda B, Ivanovic N, Granic M, Zdravkovic D, Colakovic N, Sredic B, Skuric Z, Gojgic M, Petričević, Opric S, Bjelica D

2023 CHANGING THE ROLE OF pCR IN BREAST CANCER TREATMENT – AN UNJUSTIFIABLE INTERPRETATION OF A GOOD PROGNOSTIC FACTOR AS A “FACTOR FOR A GOOD PROGNOSIS” Ivanovic N, Bjelica D, Loboda B, Bogdanovski M, Colakovic N, Petricevic S, Gojgic M, Zecic O, Zecic K, Zdravkovic D.

2024 NON-INVASIVE 3D BREAST TUMOR LOCALIZATION: A VIABLE ALTERNATIVE TO INVASIVE TUMOR MARKING Bjelica D, Colakovic N, Opric S, Zdravkovic D, Loboda B, Petricevic S, Gojgic M, Zecic O, Zecic K, Ivanović N.

Education of radiologists on screening mammography

Foreign languages:
English, French

 

Dr med. Miodrag Jašović

radiation oncologist

Dr med. Miodrag Jašović

Education:

  • 2004 Faculty of Medicine, University of Belgrade
  • 2018 Specialization in radiation oncology, Faculty of Medicine, University of Belgrade
  • 2024 Enrolled in sub-specialization in oncology, Faculty of Medicine, University of Belgrade, ongoing

Work experience:

  • 2005 – 2014 BCM-TRADE, Euro Medico Trade, Pfizer – expert associate, Lundbeck – associate for drug registration and pharmacovigilance
  • 2014 – 2018 Radius Svetozarević – clinical doctor on specialization at IORS
  • since 2018 Clinical Center of Serbia, Clinic for Neurosurgery, Center for Neurooncology, Department of Radiosurgery GAMA KNIFE – radiation oncologist

Publications and memberships:

  • 2005 DSZBPR brochure – Nutrition in cancer patients
  • 2022 Magazine “RAK” – Stereotaxic radiotherapy
  • 2023 EANS2023 Barcelona – Gamma knife treatments of recurrent metastases after previous conducted palliative radiotherapy of the whole brain
  • Member of the Serbian Medical Association and the European Association of Neurosurgeons (EANS)

Area of interest:
Radioneurosurgery

Prof. dr Elka Stefanova

neurologist

Prof. dr Elka Stefanova

Prof. Dr. Elka Stefanova is a professor of neurology with a research interest in neurodegenerative disorders: Alzheimer’s and Parkinson’s disease

Education:

  • 1984 Undergraduate studies, Faculty of Medicine, University of Belgrade
  • 1989 Master’s degree on the topic: “Neuropsychological disorders in children with congenital hypothyroidism” Faculty of Medicine, University of Belgrade
  • 1992 Specialization in neuropsychiatry, Faculty of Medicine, University of Belgrade
  • 1995 Doctoral dissertation on the topic: “Procedural and declarative memory in Parkinson’s disease and amnestic syndrome“, Faculty of Medicine, University of Belgrade

Work experience:

  • since 1987 Department of Involuntary Movements, Clinic of Neurology KCS
  • since 1987 Neuropsychiatrist, KCS Neurology Clinic
  • since 1997 Assistant, Faculty of Medicine in Belgrade
  • since 2008 Center for Memory disorders and Dementia
  • since 2010 Professor of Neurology, Faculty of Medicine in Belgrade

Professional development:

  • 1997 – 1998 Department of Experimental Psychology, Downing College, University of Cambridge, Great Britain
  • 2001 – 2003 NEUROTEC Department, Karolinska Institute, Sweden

Membership:

  • Serbian Medical Association
  • European Federation of Neurological Societies
  • EADC (European Alzheimer’s Disease Consortium)
  • ECDLB European Lewy Body Disease Consortium
  • EAN Scientific Panel Dementia and Cognitive Impairment Management Group
  • EAN Scientific Panel on Higher Cortical Functions Steering Group
  • International Association for Parkinson’s Disease and Movement Disorders (MDS)
  • Alzheimer’s Association International Society for the Advancement of Alzheimer’s Research and Treatment (ISTAART)

Publications:

Prof. Elka Stefanova has so far published 332 scientific papers, of which 108 scientific papers were published in their entirety in journals from the JCR list, Brain, Molecular Psychiatry, Alzheimer’s Dementia, Neurobiology of aging, Neuroimage, Neurogenetics, European Neurology, etc.

H -indeks 41, citation rate  5290

Languages:

English, Swedish and French